Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Homogenize "Subject" Nomenclature #14

Open
tsalo opened this issue Aug 3, 2020 · 5 comments
Open

Homogenize "Subject" Nomenclature #14

tsalo opened this issue Aug 3, 2020 · 5 comments
Labels
common-principles Proposals to change common principles. consistency Aspect requiring special treatment/logic outside of generic common principles entities Changes to entities.

Comments

@tsalo
Copy link
Member

tsalo commented Aug 3, 2020

We are currently using the terms “participant” and “subject” interchangeably. I propose we make the names homogeneous. In order to afford better extendability with preclinical research, the term “subject” would be significantly more apt.
GitHub Issue: bids-standard/bids-specification#384

This change would include renaming the participants.tsv file to subjects.tsv, and the participant_id column in said file to subject.

Original authors: @TheChymera

@tsalo tsalo changed the title Homogenize “Subject” Nomenclature Homogenize "Subject" Nomenclature Aug 3, 2020
@TheChymera
Copy link

TheChymera commented Aug 3, 2020

@tsalo thank you for bringing this up. While the urgency from my side (and that of other preclinical researchers using SAMRI) has decreased following our begrudging adoption of this element of the standard, I would again recommend this as a worthwhile change.

@tsalo tsalo added entities Changes to entities. common-principles Proposals to change common principles. labels Aug 8, 2020
@HenkMutsaerts
Copy link

I agree with this point, just brought this up with @Remi-Gau who pointed me to this issue (thanks!).
Though note that some prefer participant over subject as the latter can be derogatory. I understand that participant is tricky with preclinical research, perhaps sample would be most neutral (and generalizable) but subject would be OK with me at least.

@yarikoptic
Copy link
Contributor

yarikoptic commented Jan 26, 2024

In the light of the BEP032 (attn @bids-standard/bep032 and here #38) for animal ephys subject would also be more appropriate. So I think it is a valid target for the "immediate" BIDS 2.0 with easy "auto upgrade" path.

@SylvainTakerkart
Copy link

I agree with this point, just brought this up with @Remi-Gau who pointed me to this issue (thanks!). Though note that some prefer participant over subject as the latter can be derogatory. I understand that participant is tricky with preclinical research, perhaps sample would be most neutral (and generalizable) but subject would be OK with me at least.

just for info, "sample" is already used in BIDS (for pre-clinical research, i.e to specify that several "samples", e.g tissue slices, can be extracted from the same "subject" (animal)...

@yarikoptic
Copy link
Contributor

FTR, another definitely non-participant'y and even overall inanimate use-case came up yesterday in

so there "subject" IMHO still works as (inanimate) "subject of study".

@yarikoptic yarikoptic added the consistency Aspect requiring special treatment/logic outside of generic common principles label Apr 17, 2024
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
common-principles Proposals to change common principles. consistency Aspect requiring special treatment/logic outside of generic common principles entities Changes to entities.
Projects
Status: Done
Development

No branches or pull requests

5 participants